Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Intal Inhaler contains cromolyn sodium, a mast cell stabilizer indicated for the prophylactic management of bronchial asthma in both pediatric and adult patients. It works by inhibiting the degranulation of sensitized mast cells and preventing the release of inflammatory mediators such as histamine and leukotrienes, which are responsible for bronchospasm and airway inflammation. Intal is not a bronchodilator and is not effective for the relief of acute asthma attacks. Regular use is essential to achieve and maintain therapeutic benefit in controlling chronic asthma symptoms.
Fact Table | |
Formula | C23H14Na2O11 |
License | US FDA (Intal withdrawn from U.S. market) |
Bioavailability | ~8% (inhaled); majority excreted unchanged |
Legal status | Prescription (formerly) |
Chemical Name | Disodium cromoglycate |
Elimination half-life | ~1.3 hours |
Dosage (Strength) | 800 mcg per actuation (typical adult dose: 2 puffs QID) |
Pregnancy | Category B – no proven risk in humans |
Brands | Intal, generic cromolyn (oral and ophthalmic forms available) |
Protein binding | ~65% |
PubChem CID | 5281075 |
MedlinePlus | a600014 |
ChEBI | 3746 |
ATC code | R03BC01 |
DrugBank | DB01003 |
KEGG | D00397 |
Routes of administration | Inhaled (MDI), oral, ophthalmic, nasal |
The usual recommended dosage for adults and children over 5 years of age is:
Two inhalations (1 mg per actuation, total 2 mg) four times daily, administered via oral inhalation.
To use, shake the inhaler well and exhale fully before each inhalation. Inhale deeply while pressing down on the canister and hold breath for several seconds before exhaling. Rinse mouth after use to minimize irritation. Patients should be instructed on proper inhaler technique. Dose reduction may be considered after clinical improvement is maintained. Intal must be used regularly, and maximum benefit may take 2 to 4 weeks to be observed.
Each actuation of Intal delivers:
Cromolyn sodium 1 mg
Inactive ingredients may include:
Propellants such as CFC-12 and CFC-114, depending on the formulation and market availability
(Note: Many CFC formulations have been phased out in favor of environmentally safer propellants.)
Intal is contraindicated in patients with:
Known hypersensitivity to cromolyn sodium or any component of the formulation
Acute asthma attacks requiring immediate bronchodilation
Intal is a preventative treatment and should not be used for rapid symptom relief. Patients should continue their prescribed bronchodilator for acute attacks. Sudden withdrawal from systemic corticosteroids may result in adrenal insufficiency; tapering must be gradual and under medical supervision. Intal may not be effective in all patients, and response should be evaluated within several weeks. Use in pregnancy appears to be safe, but consult a healthcare provider before use. Not intended for use in children under 5 years of age unless prescribed.
Common and potential side effects include:
Throat irritation
Cough or hoarseness
Unpleasant taste
Sneezing or nasal congestion (if inhaled improperly)
Rare: bronchospasm, skin rash, or hypersensitivity reactions